Trial · NCT05707442
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Perimetric Mean Deviation (PMD) | 6 months | The change in perimetric mean deviation (PMD) from baseline to 6 month in the eye with the most severe visual loss at baseline. |
| Secondary | Cerebrospinal Fluid (CSF) Opening Pressure | 6 months | The change in intracranial pressure measured by lumbar puncture opening pressure from baseline to 6 months. |
| Secondary | Papilledema Grade: Frisén grade(0-5 scores,and higher scores mean worse outcome) | 6 months | The change in papilledema measured by Frisén grade from baseline to 6 months |
| Secondary | Retinal Nerve Fiber Layer Thickness | 6 months | The change in thickness of retinal nerve fiber layer measured by optical coherence tomography (OCT) from baseline to 6 months. |
| Secondary | Total Retinal Thickness | 6 months | The change in thickness of total retina measured by optical coherence tomography (OCT) from baseline to 6 months. |
| Secondary | Visual Acuity: National Eye Institute-Visual Function Questionnaire-25 (NEI-VFQ-25, minimum and maximum values: 0-100 points, higher scores mean a better visual function) | 6 months | The change in vision measured by National Eye Institute-Visual Function Questionnaire-25 (NEI-VFQ-25) from baseline to 6 months. |
| Secondary | Visual Acuity: 10-item neuro-ophthalmic supplement to the National Eye Institute-Visual Function Questionnaire-25 (NEI-VFQ-25) (minimum and maximum values: 0-100 points, higher scores mean a better visual function) | 6 months | The change in vision measured by 10-item neuro-ophthalmic supplement to the National Eye Institute-Visual Function Questionnaire-25 (NEI-VFQ-25)from baseline to 6 months. |
| Secondary | Headache: Headache Impact Test-6 (HIT-6, minimum and maximum values: 36-78 points, higher scores mean greater headache severity) | 6 months | The change in headache measured by Headache Impact Test-6 (HIT-6) questionnaire from baseline to 6 months. |
| Secondary | Pulsatile tinnitus: Tinnitus Handicap Inventory (THI, minimum and maximum values: 0-100 points, higher scores mean more serious tinnitus disability) | 6 months | The change in pulsatile tinnitus from baseline to 6 months；pulsatile tinnitus was assessed using the Tinnitus Handicap Inventory (THI), which is a self-report measure that can be used in a busy clinical practice to quantify the impact of tinnitus on daily living. |
| Other | Functional health status and quality of life:EuroQol five dimensions questionnaire (EQ-5D,0-100,higher scores mean a better outcome) | 6 months | The change in functional health status and quality of life measured by EuroQol five dimensions questionnaire (EQ-5D) from baseline to 6 months |
| Other | Cost-effectiveness analysis (mean costs per patient) | 6 months | The indicator of cost-effectiveness analysis refers to the mean costs per patient. |
| Other | Cost-effectiveness analysis (quality-adjusted life years) | 6 months | The indicator of cost-effectiveness analysis refers to the quality-adjusted life years. |
| Other | Cost-effectiveness analysis (the cost saving per extra patient with a good outcome) | 6 months | The indicator of cost-effectiveness analysis refers to the cost saving per extra patient with a good outcome. |
| Other | Cost-effectiveness analysis (the cost saving per additional quality-adjusted life year) | 6 months | The indicator of cost-effectiveness analysis refers to the cost saving per additional quality-adjusted life year. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05707442/registered